PHVS Pharvaris N.V.

NEUTRAL Impact: 2/10 144
Horizon days Filed May 20, 2026 Processed 20d 7h ago SEC 0001950047-26-004861
Form 144 — notice of proposed sale of securities
Latest settled — T+5d ⚠ clustered
PHVS ▼ -1.24% at T+5d
NEUTRAL call ✗ call lost -1.24% · α vs SPY -3.09% · entry $30.54 → $30.16
Next anchor: T+20d in 8d
Last close $31.59 (close Jun 8) · +3.44% from $30.54 entry
Entry anchored
May 20, 2026
via day open
T+1d
-2.82%
call -2.82% · α -3.26%
$29.68
settled 20d ago
T+5d
-1.24%
call -1.24% · α -3.09%
$30.16
settled 13d ago
T+20d
call — · α —
in 8d
T+60d
call — · α —
in 2mo

Price Chart

Loading chart...

Executive Summary

Form 144: Director Elisabeth Bjork intends to sell 10,000 PHVS shares (~$293K) via a cashless stock option exercise. The sale is modest relative to the company's $2.0B market cap (0.015% dilution). While the insider is a director, the amount is small and routine — this is a low-significance notification of a planned sale, not a distressed liquidation.

Actionable Insight

This is a low-concern Form 144. Director Bjork appears to be executing a cashless exercise/sale — likely to cover option exercise costs and tax obligations. No earnings catalyst or lock-up expiry coincides. The sale volume is immaterial (~0.5% of average daily volume estimate) and should not be read as a bearish signal. Monitor for Form 4 filings to confirm whether the sale actually executed.

Key Facts

  • Insider Elisabeth Bjork (Director) proposes to sell 10,000 PHVS shares
  • Estimated aggregate market value: $293,166 based on ~$29.32/share implied
  • Shares acquired via stock option exercise (cashless) on 5/20/2026
  • Sale is being conducted through Morgan Stanley Smith Barney
  • The proposed sale represents ~0.015% of the $2.0B market cap

Financial Impact

~$293K in insider selling, negligible relative to $2.0B market cap

dilution

Risk Factors

  • Form 144 is an intent notification, not a completed sale — the trade may not execute
  • Director selling at current levels may signal limited near-term upside conviction
  • Recent prior PHVS reports had negative T+5 drift, though this filing is too small to drive it

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
90% bullish (20 analysts)

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001950047-26-004861
Document: 0001950047-26-004861-index.html0001950047-26-004861
Document: 0001950047-26-004861.txt0001950047-26-004861
23 reports for PHVS
Performance horizon
80% Hit rate 4 of 5 directional calls best @ T+20▲ +11.42%Mar 20, 2026
Filters
Rows
Reports for PHVS — sortable, filterable
Type Now
May 29, 2026
11d ago
Press Release
NEUTRAL ★ 4/10
$30.16 $31.09▲ +3.08%▲ +5.61%$31.59 (+4.74%)
May 26, 2026
14d ago
Insider Cluster
NEUTRAL ★ 4/10
$29.47 $30.14▲ +2.27%▲ +1.80%$31.59 (+7.19%)
May 26, 2026
14d ago
Insider Cluster
BEARISH ★ 5/10
$29.47 $30.14▼ −2.27%▼ −1.80%$31.59 (−7.19%)
May 22, 2026
18d ago
Insider Cluster
NEUTRAL ★ 3/10
$29.68 $29.10▼ −1.95%▼ −3.63%$31.59 (+6.44%)
May 21, 2026
19d ago
144
NEUTRAL ★ 3/10
$29.68 $29.10▼ −1.95%▼ −3.61%$31.59 (+6.44%)
May 20, 2026
20d ago
Insider Cluster
NEUTRAL ★ 3/10
$30.54 $30.16▼ −1.24%▼ −3.09%$31.59 (+3.44%)
May 20, 2026
20d ago
144
NEUTRAL ★ 2/10
$30.54 $30.16▼ −1.24%▼ −3.09%$31.59 (+3.44%)
May 19, 2026
21d ago
Insider Cluster
NEUTRAL ★ 4/10
$29.45 $29.86▲ +1.39%▼ −0.41%$31.59 (+7.27%)
May 12, 2026
28d ago
Press Release
NEUTRAL ★ 5/10
$32.94 $28.95▼ −12.11%▼ −10.95%$31.59 (−4.10%)
May 11, 2026
29d ago
6-K
NEUTRAL ★ 4/10
$31.25 $28.81▼ −7.81%▼ −7.89%$31.59 (+1.09%)
Showing 10 of 23

US Market Status

Market Closed — Opens in 8h 56m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access